<DOC>
	<DOCNO>NCT02296099</DOCNO>
	<brief_summary>The purpose study determine administration liposomal bupivacaine completion suburethral sling procedure result decrease postoperative pain compare injection .</brief_summary>
	<brief_title>Trial Liposomal Bupivacaine Following Retropubic Suburethral Sling Stress Urinary Incontinence</brief_title>
	<detailed_description>The purpose study determine administration liposomal bupivacaine completion suburethral sling procedure result decrease postoperative pain compare injection . The hypothesis administration liposomal bupivacaine completion retropubic suburethral sling procedure result decrease postoperative pain compare injection . Although multiple route sling placement exist , difference pain find compare obturator verse retropubic suburethral sling . Previous trial investigate vary formulation injection along sling pathway order reduce complication pain void dysfunction . Local anesthesia along trocar pathway show improvement pain . Other technique , however , vary result . In 2011 , FDA approve liposomal bupivacaine single dose wound infiltration treatment postoperative pain follow hemorrhoidectomy bunionectomy . Initial study demonstrate decreased pain compare placebo , prolong release bimodal distribution , great sensory motor blockade . Additionally , postoperative benefit decrease overall pain , decrease opioid use , increase time opioid need observe . Liposomal bupivacaine may also advantage reduce hospital stay decrease overall hospital cost . The side effect profile similar improve rate adverse event compare traditional bupivacaine , favorable cardiac profile , increase risk poor wound heal . With promise , aim evaluate use liposomal bupivacaine reduce postoperative pain placement sling treat stress urinary incontinence . The study blind randomize control trial . Patients randomize receive liposomal bupivicaine , standard 20ml vial dilute 1 Oml saline reconstitute volume 30 ml . Those control group receive 30ml normal saline inject fashion study arm .</detailed_description>
	<mesh_term>Urinary Incontinence</mesh_term>
	<mesh_term>Enuresis</mesh_term>
	<mesh_term>Urinary Incontinence , Stress</mesh_term>
	<mesh_term>Bupivacaine</mesh_term>
	<criteria>Adults great 18 year age Planning outpatient surgical treatment stress urinary incontinence placement retropubic suburethral sling general anesthesia Pregnant nursing Allergy bupivacaine History drug/alcohol abuse Severe cardiovascular , hepatic , renal disease , neurological impairment Longacting opioid within 3 day opioid use within 24 hour surgery Contraindication : acetaminophen , oxycodone , and/or nonsteroidal antiinflammatory drug ( NSAID ) Administration investigational drug within 30 day study Chronic pain syndrome Daily NSAID/opioid use Patients concomitant procedure undergo general anesthesia</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>retropubic suburethral sling</keyword>
	<keyword>stress urinary incontinence</keyword>
	<keyword>liposomal bupivacaine</keyword>
</DOC>